FDA.MI - Fidia S.p.A.

Milan - Milan Delayed price. Currency in EUR
-0.07 (-1.14%)
As of 9:02AM CET. Market open.
Stock chart is not supported by your current browser
Previous close6.15
Bid6.06 x 40000
Ask6.16 x 73200
Day's range6.06 - 6.11
52-week range5.18 - 7.57
Avg. volume19,078
Market cap31.087M
PE ratio (TTM)N/A
EPS (TTM)-0.29
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.30
  • Business Wire5 months ago

    FIDIA PHARMA USA Inc. Continues to Expand U.S. Presence as Fidia Farmaceutici S.p.A. Leads European Orthopedic Biomaterials Market

    Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronan (HA)-based products, and its wholly owned subsidiary, FIDIA PHARMA USA Inc., are projecting continued growth in 2017. The global viscosupplementation market is anticipated to increase to over $2.64 billion by 2021, according to a research study by RnR Market Research1. Fidia Farmaceutici S.p.A. now leads the orthopedic biomaterials market in Europe after increasing its market share over the past few years.

  • We're sorry this is all we were able to find about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes